Gain a clearer context of the Centers for Medicare and Medicaid Services relationship with FDA – specifically regarding reimbursement and approval. Distinguish the data needs of CMS from FDA. Discuss practical tips to link FDA with reimbursement.
Preeya Noronha Pinto, Partner, King & Spalding LLP
This session was recorded as part of FDLI’s Virtual Introduction to Medical Device Law and Regulation Course in March 2021.